Unknown

Dataset Information

0

Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy.


ABSTRACT: This study was undertaken to evaluate the connexin hemichannel blocker tonabersat for the inhibition of inflammasome activation and use as a potential treatment for diabetic retinopathy. Human retinal pigment epithelial cells (ARPE-19) were stimulated with hyperglycemia and the inflammatory cytokines IL-1? and TNF? in order to mimic diabetic retinopathy molecular signs in vitro. Immunohistochemistry was used to evaluate the effect of tonabersat treatment on NLRP3, NLRP1, and cleaved caspase-1 expression and distribution. A Luminex cytokine release assay was performed to determine whether tonabersat affected proinflammatory cytokine release. NLRP1 was not activated in ARPE-19 cells, and IL-18 was not produced under disease conditions. However, NLRP3 and cleaved caspase-1 complex formation increased with hyperglycemia and cytokine challenge but was inhibited by tonabersat treatment. It also prevented the release of proinflammatory cytokines IL-1?, VEGF, and IL-6. Tonabersat therefore has the potential to reduce inflammasome-mediated inflammation in diabetic retinopathy.

SUBMITTER: Lyon H 

PROVIDER: S-EPMC7794685 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tonabersat Inhibits Connexin43 Hemichannel Opening and Inflammasome Activation in an In Vitro Retinal Epithelial Cell Model of Diabetic Retinopathy.

Lyon Heather H   Shome Avik A   Rupenthal Ilva D ID   Green Colin R CR   Mugisho Odunayo O OO  

International journal of molecular sciences 20201230 1


This study was undertaken to evaluate the connexin hemichannel blocker tonabersat for the inhibition of inflammasome activation and use as a potential treatment for diabetic retinopathy. Human retinal pigment epithelial cells (ARPE-19) were stimulated with hyperglycemia and the inflammatory cytokines IL-1β and TNFα in order to mimic diabetic retinopathy molecular signs in vitro. Immunohistochemistry was used to evaluate the effect of tonabersat treatment on NLRP3, NLRP1, and cleaved caspase-1 ex  ...[more]

Similar Datasets

| S-EPMC3584027 | biostudies-literature
| S-EPMC7161968 | biostudies-literature
| S-EPMC6328547 | biostudies-literature
| S-EPMC4557884 | biostudies-literature
| S-EPMC5562711 | biostudies-other
| S-EPMC9561713 | biostudies-literature
| S-EPMC1356351 | biostudies-literature
| S-EPMC5551058 | biostudies-literature
2022-12-31 | PXD034626 | Pride
| S-EPMC4365968 | biostudies-literature